Paying users zone. Data is covered by 
.
Get 1-month access to Amgen Inc. for $19.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Amgen Inc. (AMGN)
Common-Size Income Statement
Difficulty: Beginner
Amgen Inc., common-size consolidated income statement
Based on: 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-19).
| Income statement item | Description | The company |
|---|---|---|
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Amgen Inc.’s operating income as a percentage of product sales increased from 2016 to 2017 but then slightly declined from 2017 to 2018. |
| Income before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Amgen Inc.’s income before income taxes as a percentage of product sales increased from 2016 to 2017 but then slightly declined from 2017 to 2018 not reaching 2016 level. |
| Net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Amgen Inc.’s net income as a percentage of product sales declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level. |